Access Bio (950130) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Access Bio (950130) reported revenue of 22 million KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202522 million KRW-45 million KRW-58 million KRW[source]
202482 million KRW-3 million KRW-791,702 KRW[source]
2023267 million KRW17 million KRW-4 million KRW[source]
2022800 million KRW363 million KRW271 million KRW[source]
2021441 million KRW227 million KRW166 million KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025418 million KRW23 million KRW396 million KRW[source]
2024513 million KRW45 million KRW469 million KRW[source]
2023540 million KRW66 million KRW474 million KRW[source]
2022678 million KRW183 million KRW494 million KRW[source]
2021378 million KRW109 million KRW269 million KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-20 million KRW15 million KRW-3 million KRW[source]
202414 million KRW12 million KRW-5 million KRW[source]
2023-81 million KRW-36 million KRW-42 million KRW[source]
2022291 million KRW-30 million KRW-53 million KRW[source]
2021138 million KRW-29 million KRW15 million KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice